Longitude Health Adds Two New Utilities as Portfolio Growth Accelerates
Clinical Trial Services and Longitude Cell and Gene Therapy Approved by Board; Thad Wolfram and Sinthu Sinnadurai Named Executives WASHINGTON, July 21, 2026 /PRNewswire/ -- Longitude Health announced its Board of Managers approved funding for two new utilities, Longitude Clinical Trial...
View original →